IL17A and COVID-19: Another study showed a similar trend, with plasma concentrations of IL-2, IL-7, IL-17, IL-10, MCP-1, MIP-1A, IP10, and TNF-α being observed to be higher in COVID-19 patients undergoing treatment in intensive care units than in any other category of COVID-19 patients (91).